Search Results - "Ottewell, D"

Refine Results
  1. 1

    The role of osteoblasts in bone metastasis by Ottewell, Penelope D

    Published in Journal of bone oncology (01-09-2016)
    “…Abstract The primary role of osteoblasts is to lay down new bone during skeletal development and remodelling. Throughout this process osteoblasts directly…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone by Ottewell, Penelope D, Wang, Ning, Meek, Joshua, Fowles, C Anne, Croucher, Peter I, Eaton, Colby L, Holen, Ingunn

    Published in Endocrine-related cancer (01-10-2014)
    “…Up to 90% of patients with castrate-resistant prostate cancer develop bone metastases, and the majority of these men have received androgen deprivation therapy…”
    Get full text
    Journal Article
  5. 5

    The role of IL-1B in breast cancer bone metastasis by Zhou, Jiabao, Ottewell, Penelope D.

    Published in Journal of bone oncology (01-06-2024)
    “…•Promoting EMT, vascular and immunological changes that drive tumour cells out of the primary site.•Regulates breast cancer cell homing to the bone…”
    Get full text
    Journal Article
  6. 6

    Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer by Ottewell, Penelope D., Mönkkönen, Hannu, Jones, Mark, Lefley, Diane V., Coleman, Robert E., Holen, Ingunn

    “…Background The potent antiresorptive drug zoledronic acid (Zol) enhances the antitumor effects of chemotherapy agents in vitro. We investigated the effects of…”
    Get full text
    Journal Article
  7. 7

    Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer by Quayle, Lewis, Ottewell, Penelope D, Holen, Ingunn

    Published in Current cancer drug targets (01-08-2015)
    “…Metastasis to the bone is most frequently observed in advanced cases of breast and prostate cancer. The latent development of overt metastatic lesions is…”
    Get more information
    Journal Article
  8. 8

    The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo by Allocca, Gloria, Hughes, Russell, Wang, Ning, Brown, Hannah K, Ottewell, Penelope D, Brown, Nicola J, Holen, Ingunn

    Published in Journal of bone oncology (01-08-2019)
    “…Background: Bone metastasis is one of the most common complications of advanced breast cancer. During dissemination to bone, breast cancer cells locate in a…”
    Get full text
    Journal Article
  9. 9

    Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer by Brown, Hannah K, Allocca, Gloria, Ottewell, Penelope D, Wang, Ning, Brown, Nicola J, Croucher, Peter I, Eaton, Colby L, Holen, Ingunn

    “…Breast cancer cells colonize the skeleton by homing to specific niches, but the involvement of osteoblasts in tumour cell seeding, colonization, and…”
    Get full text
    Journal Article
  10. 10

    Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women by Canuas-Landero, Victor G, George, Christopher N, Lefley, Diane V, Corness, Hannah, Muthana, Munitta, Wilson, Caroline, Ottewell, Penelope D

    Published in Frontiers in endocrinology (Lausanne) (18-10-2021)
    “…Clinical trials have demonstrated that adding zoledronic acid (Zol) to (neo)adjuvant standard of care has differential antitumour effects in pre- and…”
    Get full text
    Journal Article
  11. 11

    Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model by Ottewell, Penelope D., Lefley, Diane V., Cross, Simon S., Evans, C. Alyson, Coleman, Robert E., Holen, Ingunn

    Published in International journal of cancer (15-01-2010)
    “…Combination therapy, using agents that target the microenvironment as well as the cancer cells, is common in the treatment of advanced breast cancer. Here, we…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGFB signalling in vitro and in an OIM mouse model by Morita, Mai, Arshad, Fawaz, Quayle, Lewis A., George, Christopher N., Lefley, Diane V., Kalajzic, Ivo, Balsubramanian, Meena, Cebe, Tugba, Reilly, Gwen, Bishop, Nicolas J., Ottewell, Penelope D.

    Published in Bone Reports (01-09-2024)
    “…Excessive production of Transforming Growth Factor β (TGFβ) is commonly associated with dominant and recessive forms of OI. Previous reports have indicated…”
    Get full text
    Journal Article
  14. 14

    Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo by Ottewell, Penelope D, Deux, Blandine, Mönkkönen, Hannu, Cross, Simon, Coleman, Robert E, Clezardin, Philippe, Holen, Ingunn

    Published in Clinical cancer research (15-07-2008)
    “…Purpose: Breast cancer patients with bone metastases are commonly treated with chemotherapeutic agents such as doxorubicin and zoledronic acid to control their…”
    Get full text
    Journal Article
  15. 15

    Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo by Holen, Ingunn, Whitworth, Jacob, Nutter, Faith, Evans, Alyson, Brown, Hannah K, Lefley, Diane V, Barbaric, Ivana, Jones, Mark, Ottewell, Penelope D

    Published in Breast cancer research : BCR (25-05-2012)
    “…The majority of deaths from breast cancer are a result of metastases; however, little is understood about the genetic alterations underlying their onset…”
    Get full text
    Journal Article
  16. 16

    Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone by Ottewell, Penelope D, Woodward, Julia K, Lefley, Diane V, Evans, C Alyson, Coleman, Robert E, Holen, Ingunn

    Published in Molecular cancer therapeutics (01-10-2009)
    “…Patients with advanced breast cancer frequently develop bone metastases, and at this stage, the disease is considered incurable. Here, we show that a 6-week…”
    Get full text
    Journal Article
  17. 17

    Combined therapies of bone disease with bisphosphonates by Syddall, S P, Ottewell, P D, Holen, I

    Published in Current pharmaceutical design (01-01-2010)
    “…Bisphosphonates are standard treatment for cancer-induced bone disease, a common feature of many advanced malignancies. Traditionally used to inhibit bone…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine by Marshman, Emma, Ottewell, Penelope D., Potten, Christopher S., Watson, Alastair J. M.

    Published in The Journal of pathology (01-10-2001)
    “…The aim of this study was to characterize the activation of caspase‐3 along the crypt/villus axis in the normal and irradiated intestine and to compare active…”
    Get full text
    Journal Article
  20. 20

    IL-1β in breast cancer bone metastasis by Zhou, Jiabao, Tulotta, Claudia, Ottewell, Penelope D

    Published in Expert reviews in molecular medicine (01-03-2022)
    “…Bone is the most common site for advanced breast cancer to metastasise. The proinflammatory cytokine, interleukin-1β (IL-1β) plays a complex and contradictory…”
    Get more information
    Journal Article